0000899243-23-001007.txt : 20230105 0000899243-23-001007.hdr.sgml : 20230105 20230105163542 ACCESSION NUMBER: 0000899243-23-001007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230104 FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fraser Claire CENTRAL INDEX KEY: 0001382031 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37465 FILM NUMBER: 23511961 MAIL ADDRESS: STREET 1: C/O BECTON, DICKINSON AND COMPANY CITY: FRANKLIN LAKES STATE: NJ ZIP: 07465 FORMER NAME: FORMER CONFORMED NAME: Fraser-Liggett Claire DATE OF NAME CHANGE: 20061122 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seres Therapeutics, Inc. CENTRAL INDEX KEY: 0001609809 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274326290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617 945 9626 MAIL ADDRESS: STREET 1: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Seres Health, Inc. DATE OF NAME CHANGE: 20140603 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-04 0 0001609809 Seres Therapeutics, Inc. MCRB 0001382031 Fraser Claire C/O SERES THERAPEUTICS, INC. 200 SIDNEY STREET CAMBRIDGE MA 02139 1 0 0 0 Stock Option (right to buy) 5.47 2023-01-04 4 A 0 48000 0.00 A 2033-01-03 Common Stock 48000 48000 D The option will vest in four equal installments on each anniversary of January 4, 2023 or in full immediately prior to the occurrence of a change in control. /s/ Thomas J. DesRosier, Attorney-in-fact for Claire Fraser 2023-01-05